BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Zhen Long Ng, Jiamin Siew, Jia Li, Guanxu Ji, Min Huang, Xiaohua Liao, Sue Yu, Yuanyuan Chew, Chin Wen Png, Yongliang Zhang, Shijun Wen, Henry Yang, Yiting Zhou, Yun Chau Long, Zhi Hong Jiang, Qiang Wu. PATZ1 (MAZR) Co-occupies Genomic Sites With p53 and Inhibits Liver Cancer Cell Proliferation via Regulating p27Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.586150
2
HONG-JUN LI, QI-MAN SUN, LONG-ZI LIU, JUN ZHANG, JUN HUANG, CHENG-HONG WANG, RUI DING, KANG SONG, ZHONG TONG. High expression of IL-9R promotes the progression of human hepatocellular carcinoma and indicates a poor clinical outcomeOncology Reports 2015; 34(2): 795 doi: 10.3892/or.2015.4060
3
Xiaodong Wang, Dongying Chen, Bin Chen. The Long-To-Short-Axis Ratio and Multifocality are Associated With TP53 Mutation Status in Surgically Resected Hepatocellular CarcinomasAcademic Radiology 2020; 27(12): 1720 doi: 10.1016/j.acra.2018.04.021
4
Aloísio Felipe-Silva, Alda Wakamatsu, Cinthya dos Santos Cirqueira, Venâncio Avancini Ferreira Alves. Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy casesWorld Journal of Gastroenterology 2016; 22(27): 6246-6256 doi: 10.3748/wjg.v22.i27.6246
5
Hui Xiong, Yuan-Lin Zeng. Standard-b-Value Versus Low-b-Value Diffusion-Weighted Imaging in Hepatic Lesion DiscriminationJournal of Computer Assisted Tomography 2016; 40(3): 498 doi: 10.1097/RCT.0000000000000377
6
Marie Lequoy, Christèle Desbois-Mouthon, Dominique Wendum, Vandana Gupta, Jean-Luc Blachon, Olivier Scatton, Sylvie Dumont, Mireille Bonnemaire, Fabien Schmidlin, Olivier Rosmorduc, Laetitia Fartoux. Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosisHistopathology 2017; 70(3): 492 doi: 10.1111/his.13034
7
Haoyu Sun, Jing Xu, Mei Huang, Qiang Huang, Rui Sun, Weihua Xiao, Cheng Sun. CD200R, a co-inhibitory receptor on immune cells, predicts the prognosis of human hepatocellular carcinomaImmunology Letters 2016; 178: 105 doi: 10.1016/j.imlet.2016.08.009
8
M. A. Abdelwa, M. M. Elbedew, A. M. Amin, A. K. Tawfik. Serum Endoglin and IL-6 Levels as Complementary Diagnostic Biomarkers for Hepatocellular Carcinoma in Egyptian Liver Cirrhosis PatientsResearch Journal of Immunology 2016; 10(1): 1 doi: 10.3923/rji.2017.1.7
9
Xin-Xing Hu, Wen-Tao Wang, Li Yang, Zhao-Xia Yang, He-Yue Liang, Ying Ding, Yuan Ji, Meng-Su Zeng, Sheng-Xiang Rao. MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomasEuropean Journal of Radiology 2019; 113: 7 doi: 10.1016/j.ejrad.2019.01.036
10
Xin Yuan, Yize Zhang, Zujiang Yu. Expression and clinical significance of miR-3615 in hepatocellular carcinomaJournal of International Medical Research 2021; 49(1): 030006052098154 doi: 10.1177/0300060520981547
11
Da-Wei Sun, Lin An, Feng Wei, Lin Mu, Xiao-Ju Shi, Chuan-Lei Wang, Zheng-Wei Zhao, Teng-Fei Li, Guo-Yue Lv. Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysisAbdominal Radiology 2016; 41(1): 33 doi: 10.1007/s00261-015-0603-9